“We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Facing Tense IP And Health Talks, WHO Board Erupts Into Dance (Video) 26/01/2018 William New Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and ... dancing. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 Catherine Saez The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed. Continue reading -> WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Facing Tense IP And Health Talks, WHO Board Erupts Into Dance (Video) 26/01/2018 William New Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and ... dancing. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 Catherine Saez The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed. Continue reading -> WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
Facing Tense IP And Health Talks, WHO Board Erupts Into Dance (Video) 26/01/2018 William New Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and ... dancing. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 Catherine Saez The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed. Continue reading -> WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 Catherine Saez The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed. Continue reading -> WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 Catherine Saez The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed. Continue reading -> WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 William New The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women's majority in the senior leadership of the organisation - a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 Catherine Saez A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes. Continue reading -> Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 Catherine Saez A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general. Continue reading -> Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts
Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 William New After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.] Continue reading -> Posts navigation Older postsNewer posts